De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lambert, Jennifer E ^a   Ryan, Edmond A ^a   Thomson, Alan B R ^a   Clandinin, Michael T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; DEUTERIUM; FATTY ACID; INSULIN GLARGINE; INSULIN LISPRO; LIPID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; VERY LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE DURATION; FATTY ACID SYNTHESIS; FEMALE; FOOD INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOGENESIS; MALE; MASS SPECTROMETRY; MEAL; MIDDLE AGED; POSTPRANDIAL STATE; SEX RATIO; YOUNG ADULT; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; LIVER; METABOLISM;

CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL ESTERS; DIABETES MELLITUS, TYPE 1; FASTING; FATTY ACIDS; FEMALE; HUMANS; LIPOGENESIS; LIPOPROTEINS, VLDL; LIVER; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84893504813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082530     Document Type: Article

References (61)

1. Orchard TJ, Costacou T (2010) When are type 1 diabetic patients at risk for cardiovascular disease? Curr Diab Rep 10: 48-54.
2. Wilke MS, French MA, Goh YK, Ryan EA, Jones PJ, et al (2009) Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 52: 1628-1637.
3. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351.
4. Diraison F, Moulin P, Beylot M (2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 29: 478-485.
5. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, et al (2010) Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 53: 713-718.
6. Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, et al (2012) Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55: 1389-1397.
7. Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, et al (2011) Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes 60: 306-314.
8. Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, et al (2012) Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes. J Clin Endocrinol Metab 97: 1663-1672.
9. Feingold KR, Moser A, Adi S, Soued M, Grunfeld C (1990) Small intestinal fatty acid synthesis is increased in diabetic rats. Endocrinology 127: 2247-2252.
10. Bloks VW, Bakker-Van Waarde WM, Verkade HJ, Kema IP, Wolters H, et al (2004) Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 47: 104-112.
11. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, et al (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96: 13656-13661.
12. Clandinin MT, Cheema S, Field CJ, Garg ML, Venkatraman J, et al (1991) Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5: 2761-2769.
13. Jones PJ, Leitch CA, Li ZC, Connor WE (1993) Human cholesterol synthesis measurement using deuterated water. Theoretical and procedural considerations. Arterioscler Thromb 13: 247-253.
14. Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, et al (2013) The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab 98: E40-E50.
15. ADA (2012) Executive summary: standards of medical care in diabetes - 2012. Diabetes Care 35: S4-S10.
16. Gylling H, Tuominen JA, Koivisto VA, Miettinen TA (2004) Cholesterol metabolism in type 1 diabetes. Diabetes 53: 2217-2222.
17. Gylling H, Laaksonen DE, Atalay M, Hallikainen M, Niskanen L, et al (2007) Markers of absorption and synthesis of cholesterol in men with type 1 diabetes. Diabetes Metab Res Rev 23: 372-377.
18. Miettinen TA, Gylling H, Tuominen J, Simonen P, Koivisto V (2004) Low synthesis and high absorption of cholesterol characterize type 1 diabetes. Diabetes Care 27: 53-58.
19. Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, et al (2010) Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes 59: 1771-1779.
20. Rideout TC, Harding SV, Mackay D, Abumweis SS, Jones PJ (2010) High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am J Clin Nutr 92: 41-46.
21. Jones PJ (1990) Use of deuterated water for measurement of short-term cholesterol synthesis in humans. Can J Physiol Pharmacol 68: 955-959.
22. Gremaud G, Piguet C, Baumgartner M, Pouteau E, Decarli B, et al (2001) Simultaneous assessment of cholesterol absorption and synthesis in humans using on-line gas chromatography/combustion and gas chromatography/pyrolysis/isotope- ratio mass spectrometry. Rapid Commun Mass Spectrom 15: 1207-1213.
23. Diraison F, Pachiaudi C, Beylot M (1997) Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom 32: 81-86.
24. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
25. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069.
26. Pappu AS, Bacon SP, Illingworth DR (2003) Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. J Lab Clin Med 141: 250-256.
27. Pfohl M, Naoumova RP, Kim KD, Thompson GR (1998) Use of cholesterol precursors to assess changes in cholesterol synthesis under non-steady-state conditions. Eur J Clin Invest 28: 491-496.
28. De Cuyper I, Wolthers BG, van Doormaal JJ, Wijnandts PN (1993) Determination of changes in serum lathosterol during treatment with simvastatin to evaluate the role of lathosterol as a parameter for whole body cholesterol synthesis. Clin Chim Acta 219: 123-130.
29. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, et al (2005) Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28: 301-306.
30. Myrie SB, Mymin D, Triggs-Raine B, Jones PJ (2012) Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals. Am J Clin Nutr 95: 837-844.
31. Pouteau E, Piguet-Welsch C, Berger A, Fay LB (2003) Determination of cholesterol absorption in humans: from radiolabel to stable isotope studies. Isotopes Environ Health Stud 39: 247-257.
32. Konrad SD, Cook SL, Goh YK, French MA, Clandinin MT (1998) Use of deuterium oxide to measure de novo fatty acid synthesis in normal subjects consuming different dietary fatty acid composition. Biochim Biophys Acta 1393: 143-152.
33. Jungas RL (1968) Fatty acid synthesis in adipose tissue incubated in tritiated water. Biochemistry 7: 3708-3717.
34. Leitch CA, Jones PJ (1991) Measurement of triglyceride synthesis in humans using deuterium oxide and isotope ratio mass spectrometry. Biol Mass Spectrom 20: 392-396.
35. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD (1965) Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method. Adv Surg 1: 69-109.
36. Mackay D, Jones PJ (2011) Evaluation of methods for the determination of cholesterol absorption and synthesis in humans. Atherosclerosis 218: 253-262.
37. Goodman DS, Smith FR, Seplowitz AH, Ramakrishnan R, Dell RB (1980) Prediction of the parameters of whole body cholesterol metabolism in humans. J Lipid Res 21: 699-713.
38. Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77: 43-50.
39. Browning JD, Baker JA, Rogers T, Davis J, Satapati S, et al (2011) Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93: 1048-1052.
40. Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK (1995) Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96: 2735-2743.
41. Lammert O, Grunnet N, Faber P, Bjørnsbo KS, Dich J, et al (2000) Effects of isoenergetic overfeeding of either carbohydrate or fat in young men. Br J Nutr 84: 233-245.
42. McDevitt RM, Bott SJ, Harding M, Coward WA, Bluck LJ, et al (2001) De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr 74: 737-746.
43. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, et al (1996) Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 97: 2081-2091.
44. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, et al (2000) Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res 41: 595-604.
45. Hudgins LC, Seidman CE, Diakun J, Hirsch J (1998) Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am J Clin Nutr 67: 631-639.
46. Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martínez JA (2001) Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am J Clin Nutr 73: 253-261.
47. Parks EJ, Skokan LE, Timlin MT, Dingfelder CS (2008) Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 138: 1039-1046.
48. Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, et al (2010) Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res.
49. Harding SV, Rideout TC, Jones PJ (2010) Hepatic nuclear sterol regulatory binding element protein 2 abundance is decreased and that of ABCG5 increased in male hamsters fed plant sterols. J Nutr 140: 1249-1254.
50. Hallikainen M, Kurl S, Laakso M, Miettinen TA, Gylling H (2011) Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol. Atherosclerosis 217: 473-478.
51. Berthold HK, Mertens J, Birnbaum J, Brämswig S, Sudhop T, et al (2010) Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemia. Lipids 45: 491-500.
52. Su JW, Lambert JE, Clandinin MT, Proctor SD (2009) Impaired postprandial metabolism of apolipoprotein B48-containing remnant particles in normolipidemic subjects with brittle type 1 diabetes. Diabetes Care 32: e21.
53. Mangat R, Su JW, Lambert JE, Clandinin MT, Wang Y, et al (2011) Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. Diabet Med 28: 61-72.
54. Rideout TC, Harding SV, Marinangeli CP, Jones PJ (2010) Combination drug-diet therapies for dyslipidemia. Transl Res 155: 220-227.
55. Matthan NR, Raeini-Sarjaz M, Lichtenstein AH, Ausman LM, Jones PJ (2000) Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women. Lipids 35: 1037-1044.
56. Sittiwet C, Gylling H, Hallikainen M, Pihlajamäki J, Moilanen L, et al (2007) Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: the effect of improved glycemic control. Atherosclerosis 194: 465-472.
57. Raeini-Sarjaz M, Vanstone CA, Papamandjaris AA, Wykes LJ, Jones PJ (2001) Comparison of the effect of dietary fat restriction with that of energy restriction on human lipid metabolism. Am J Clin Nutr 73: 262-267.
58. Jones PJ, Lichtenstein AH, Schaefer EJ, Namchuk GL (1994) Effect of dietary fat selection on plasma cholesterol synthesis in older, moderately hypercholesterolemic humans. Arterioscler Thromb 14: 542-548.
59. Mazier MJ, Jones PJ (1997) Diet fat saturation and feeding state modulate rates of cholesterol synthesis in normolipidemic men. J Nutr 127: 332-340.
60. Jones PJ, Pappu AS, Hatcher L, Li ZC, Illingworth DR, et al (1996) Dietary cholesterol feeding suppresses human cholesterol synthesis measured by deuterium incorporation and urinary mevalonic acid levels. Arterioscler Thromb Vasc Biol 16: 1222-1228.
61. Jones PJ, Main BF, Frohlich JJ (1993) Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism 42: 1065-1071.